DE-CSC
7.3.2019 15:02:12 CET | Business Wire | Press release
CSC joins the U.S. Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency, the UK National Cyber Security Centre, and other leading security organizations—including Cisco® Talos, FireEye® , and Akamai—in alerting corporations and the public to the recent widespread, state-sponsored domain name system (DNS) hijacking attacks. The targets of these recent attacks include government, corporate, telecommunication, and infrastructure entities resulting in website and email redirection to collect sensitive information. We urge companies to stay vigilant and employ security protocols to reduce exposure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190307005082/en/
“DNS attacks can lead to criminals redirecting web traffic away from a legitimate site to a rogue site, putting customers and companies at great risk,” says Mark Flegg, product director for Security Services at CSC. “The recent attacks are complex and vicious, exploiting weaknesses in DNS infrastructure that many companies set up once, then neglect. We strongly advise clients to use the tools and recommendations available to get their digital infrastructure secure.”
In response to DNS hijacking risk and other cyber crime, CSC introduced CSC Security CenterSM in 2018. It’s an online interface powered by advanced proprietary algorithms designed to expose security blind spots across domain names, DNS, and digital certificates that make vital online brand assets susceptible to DNS hijacking, phishing, and distributed denial of service attacks.
“Domain and DNS hijacking are not new security threats, which is why we developed CSC Security Center and are encouraged that hundreds of the world's largest companies are using it to help protect these critical online elements that enable them to operate,” says CSC Digital Brand Services General Manager Mark Calandra. “The sophistication and impact of the recent wave of attacks serves as a wakeup call that effectively managing domain names, DNS, and digital certificates needs to be a critical component for enhancing the security posture of any company with an online presence.”
CSC Security Center proactively identifies business-critical domains, and monitors them continually to ensure they’re protected. This includes checking for registry- and registrar-level locks that prevent unauthorized changes, reviewing user permissions, and verifying that security-focused, enterprise-class DNS hosting and digital certificates are implemented.
“The new CSC Security Center was a welcome surprise,” says Altan Changezi, lead infrastructure architect at Manulife. “It very quickly allows me to see—at a high level—our overall digital asset configuration at CSC. This includes the status of our most vital domains, as well as the number of users with privileged access to our CSC-managed web portals. The tool allows us to make proactive decisions to take control of our assets, as well as secure our accounts.”
The constant identification and monitoring of vital domains alerting companies to security blind spots allows them to take quick action to reduce real-world online threats to their web presence, customer data, and business-critical functions.
“CSC Security Center has shown us where we needed to consolidate providers, update our permissions and security protocols to be consistent with the importance of the website, and much more,” says John Howell, IT operations manager at Football Federation Australia. “The interface is user friendly and alerts us to where we need to keep watch or increase security. I’ve never seen anything like it before, and knowing I can chat with my CSC rep about any of the security blind spots that are revealed—and get protected right away—gives us peace of mind that our data and customers are protected.”
CSC Security Center helps clients reduce exposure to cyber crime by providing them a single view into all risk areas.
About CSC
CSC helps businesses thrive online. We help effectively manage, promote, and secure our clients’ valuable brand assets against the threats of the online world. Leading companies around the world choose us to be their trusted partner, including more than 65% of the Interbrand® 100 Best Global Brands. Leveraging state-of-the-art technology, Digital Brand Services delivers outstanding outcomes through our unique account management structure. With our expert, dedicated team, you’ll have a daily point of contact to ensure your brand has the strength it needs to succeed in the 21st century. We help consolidate and secure, monitor and enforce, then optimize and promote your brands to maximize your digital presence, secure your digital intellectual property, and reduce costs. CSC is the world’s leading provider of digital brand services to companies around the globe. Headquartered in Wilmington, Delaware, CSC also operates from offices throughout the U.S., Canada, Europe, and the Asia-Pacific region. Learn more at cscdigitalbrand.services .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190307005082/en/
Contact:
Laura Crozier Public Relations Manager, USA (302) 693-5401 x. 65526 laura.crozier@cscglobal.com
Marie Le Maitre Global Marketing Manager, EMEA +44 (0)20 75132324 marie.lemaitre@cscglobal.com
Letitia Thian Marketing Manager, APAC +65 6709 0104 x. 80104 letitia.thian@cscglobal.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
